Overview

A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations

Status:
Completed

Trial end date:
2009-02-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether topical application of PEP005 is effective for the treatment of actinic keratoses.

Phase:

Phase 3

Details

Lead Sponsor:

Peplin